Consultant Haematologist with subspecialty expertise in haemostasis, thrombosis, haemoglobinopathies, and malignant haematology.

Experienced in providing independent expert opinion through evidence-based analysis of complex clinical care pathways and assessment of whether management meets accepted UK standards of care.

Regularly involved in formal investigation of adverse clinical outcomes through Serious Adverse Event reviews, Root Cause Analysis, and complaints investigations within a large tertiary NHS teaching hospital.

I am Chair of the Sector Thrombosis Committee & MDT and have led the development of regional haemostasis and thrombosis guidelines, providing insight into how clinical standards are applied in practice.

Accepting instructions across:

General and specialist haematology, including sickle cell disease and other haemoglobinopathies, thrombosis, venous thromboembolism, anticoagulation, thrombophilia, bleeding disorders, haemophilia and  thrombocytopenia.

Heparin-induced thrombocytopenia, immune thrombocytopenia, thrombotic thrombocytopenic purpura, thrombotic microangiopathy, transfusion medicine and transfusion reactions, anaemia, neutropenia, myeloma, lymphoma, leukaemia and other haematological malignancies.

Particular expertise in complex thrombosis, pulmonary embolism, deep vein thrombosis, perioperative haematology, treatment complications, causation and prognosis.